Abstract
Influenza A virus infection begins with the attachment of virus particles to sialic acid-containing receptors on the surface of host cells. This attachment is mediated by the viral surface glycoprotein hemagglutinin (HA). Influenza A viruses have a wide host range, meaning they are able to infect many mammal and bird species. Influenza pandemics have been caused by viruses that contain genes from avian influenza viruses. Therefore, the infection of humans with avian influenza viruses, including avian H5Nx and H7Nx viruses, poses a huge threat to public health. These avian influenza viruses can transmit directly to humans from infected poultry, but do not spread easily among people, in part, due to differences in the receptor-binding specificities of human and avian influenza viruses. Therefore, conversion from avian- to human-type receptor-binding specificity is widely believed to be necessary for the efficient transmission of avian influenza viruses among humans. Accordingly, constant monitoring of the receptor-binding specificity of avian influenza viruses is important. In this chapter, we describe the protocol for assessing the receptor-binding specificity of influenza A viruses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Laver WG, Webster RG (1979) Ecology of influenza viruses in lower mammals and birds. Br Med Bull 35:29–33
Long JS, Mistry B, Haslam SM, Barclay WS (2019) Host and viral determinants of influenza A virus species specificity. Nat Rev Microbiol 17:67–81
World Health Organization. Regional Office for the Western Pacific (2021) Avian influenza weekly update 2021. WHO Regional Office for the Western Pacific. https://apps.who.int/iris/handle/10665/341148
Connor RJ, Kawaoka Y, Webster RG, Paulson JC (1994) Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205:17–23
Rogers GN, Paulson JC (1983) Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361–373
Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC et al (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355:1143–1155
Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435–436
van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD et al (2006) H5N1 virus attachment to lower respiratory tract. Science 312:399
Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR et al (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367–7373
Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR et al (2000) Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74:8502–8512
Ozawa M, Victor ST, Taft AS, Yamada S, Li C, Hatta M et al (2011) Replication-incompetent influenza A viruses that stably express a foreign gene. J Gen Virol 92:2879–2888
Victor ST, Watanabe S, Katsura H, Ozawa M, Kawaoka Y (2012) A replication-incompetent PB2-knockout influenza A virus vaccine vector. J Virol 86:4123–4128
Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275–2289
Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345–9350
Horimoto T, Murakami S, Muramoto Y, Yamada S, Fujii K, Kiso M et al (2007) Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 366:23–27
Murakami S, Horimoto T, Mai LQ, Nidom CA, Chen H, Muramoto Y et al (2008) Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells. J Virol 82:10502–10509
Ping J, Lopes TJS, Nidom CA, Ghedin E, Macken CA, Fitch A et al (2015) Development of high-yield influenza A virus vaccine viruses. Nat Commun 6:8148
Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K et al (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420–428
Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T et al (2013) A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine. Vaccine 31:6239–6246
Imai M, Watanabe T, Kiso M, Nakajima N, Yamayoshi S, Iwatsuki-Horimoto K et al (2017) A highly pathogenic avian H7N9 influenza virus isolated from a human is lethal in some ferrets infected via respiratory droplets. Cell Host Microbe 22:615–626
Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, García-Sastre A (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73:9679–9682
Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113
Chambers BS, Li Y, Hodinka RL, Hensley SE (2014) Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol 88:10986–10989
Lin Y, Wharton SA, Whittaker L, Dai M, Ermetal B, Lo J et al (2017) The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells. Influenza Other Respir Viruses 11:263–274
Takada K, Kawakami C, Fan S, Chiba S, Zhong G, Gu C et al (2019) A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses. Nat Microbiol 4:1268–1273
Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K et al (2005) Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43:4139–4146
Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD (2003) Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 77:8418–8425
Acknowledgments
We thank Susan Watson for scientific editing.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Imai, M., Takada, K., Kawaoka, Y. (2022). Receptor-Binding Specificity of Influenza Viruses. In: Suzuki, Y. (eds) Glycovirology. Methods in Molecular Biology, vol 2556. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2635-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2635-1_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2634-4
Online ISBN: 978-1-0716-2635-1
eBook Packages: Springer Protocols